These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 12837046

  • 1. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

  • 3. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [Abstract] [Full Text] [Related]

  • 4. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
    Castaño G, Más R, Fernández L, Illnait J, Mendoza S, Gámez R, Fernández J, Mesa M.
    Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
    [Abstract] [Full Text] [Related]

  • 9. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
    Pons P, Rodríguez M, Robaina C, Illnait J, Más R, Fernández L, Fernández JC.
    Int J Clin Pharmacol Res; 1994; 14(1):27-33. PubMed ID: 7927958
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.
    Alcocer L, Fernández L, Campos E, Más R.
    Int J Tissue React; 1999; 21(3):85-92. PubMed ID: 10645516
    [Abstract] [Full Text] [Related]

  • 11. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
    Prat H, Román O, Pino E.
    Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 13. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [Abstract] [Full Text] [Related]

  • 14. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia.
    Canetti M, Moreira M, Mas R, Illnait J, Fernandez L, Fernandez J, Diaz E, Castano G.
    Int J Clin Pharmacol Res; 1995 Nov; 15(4):159-65. PubMed ID: 8871266
    [Abstract] [Full Text] [Related]

  • 15. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003 Nov; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 16. Policosanol: a new treatment for cardiovascular disease?
    Janikula M.
    Altern Med Rev; 2002 Jun; 7(3):203-17. PubMed ID: 12126462
    [Abstract] [Full Text] [Related]

  • 17. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.
    Drugs R D; 2005 Jun; 6(4):207-19. PubMed ID: 16050054
    [Abstract] [Full Text] [Related]

  • 18. Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study.
    Batista J, Stüsser R, Saéz F, Pérez B.
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):134-7. PubMed ID: 8705091
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 20. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N, Ramires JA.
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.